Indications: Benign prostatic hyperplasia (BPH) type I and II
Actions: Decreases the levels of type I and type II isomers of the fifth-reductase (an enzyme associated with the conversion of testosterone to dyidrotestosteroni). Inhibits the binding of dihydrotestosterone to cellular androgen receptors in prostate cells. Undermine the progress of inflammation. It inhibits the proliferation of prostatic epithelial cells. Relaxes muscles. Reduces prostate volume. Relieves symptoms of benign prostatic hyperplasia as urinary frequency, nocturia, delayed start of urination, feeling of incomplete emptying of the bladder, weakness or failure of the package of urine. Improves quality of life.
Dosage: One to two tablets twice daily for 3 to 6 months.
Side Effects - Interactions: Very well tolerated. Gastro complaints appear rare. Avoided when taking Prosteez of with meals. There are no reported interactions Prosteez with other substances. There are no side effects such as incontinence, impotence, retrograde ejaculation. Contraindicated in patients with severe urinary retention.